Role of Severe Acute Respiratory Syndrome Coronavirus Viroporins E, 3a, and 8a in Replication and Pathogenesis

Carlos Castaño-Rodriguez1, Jose M Honrubia1, Javier Gutiérrez-Álvarez1

  • 1Department of Molecular and Cell Biology, Centro Nacional de Biotecnología (CNB-CSIC), Campus Universidad Autónoma de Madrid, Madrid, Spain.

Mbio
|May 24, 2018
PubMed

Insights

Severe acute respiratory syndrome coronavirus (SARS-CoV) E and 3a viroporins are crucial for virus replication and virulence. The E protein

Area of Science:

  • Virology
  • Molecular Biology
  • Immunology

Background:

  • Viroporins are viral proteins with ion channel (IC) activity essential for virus replication and pathogenesis.
  • Coronaviruses (CoVs) encode multiple viroporins; SARS-CoV encodes three: 3a, E, and 8a.
  • Proteins 3a and E possess PDZ-binding motifs (PBMs) that interact with cellular proteins, influencing host cell functions.

Purpose of the Study:

  • To comparatively analyze the functional roles of ion channel (IC) and PDZ-binding motif (PBM) domains in SARS-CoV proteins 3a and E.
  • To determine the impact of these viroporins and their motifs on SARS-CoV replication, virulence, and pathogenesis.

Main Methods:

  • Comparative functional analysis of SARS-CoV viroporins (3a, E, 8a) and their motifs (IC, PBM).
  • Assessment of virus replication and virulence in vitro and in vivo (mice).
  • Generation of virus mutants lacking specific proteins or functional motifs.

Main Results:

  • Full-length SARS-CoV E and 3a proteins are essential for maximal viral replication and virulence.
  • A virus lacking both E and 3a proteins is non-viable; either protein with a functional PBM restores viability.
  • E protein's IC activity and PBM are critical for mouse virulence, while 3a's motifs do not affect pathogenicity.
  • The E protein's IC and PBM dominate over 3a's in inducing pathogenesis.

Conclusions:

  • The ion channel and PBM domains of SARS-CoV viroporins play key roles in viral replication and pathogenesis.
  • Viral viroporins and PBMs represent promising targets for antiviral therapies.
  • Targeting these domains could lead to the development of attenuated SARS-CoV vaccines.

Related Concept Videos

Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
1.1K
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.1K
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
510
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.1K
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
926
Acute Respiratory Failure-IV01:23

Acute Respiratory Failure-IV

Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
578